These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 19398291

  • 1. Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
    Takenaka D, Ohno Y, Koyama H, Nogami M, Onishi Y, Matsumoto K, Matsumoto S, Yoshikawa T, Sugimura K.
    Eur J Radiol; 2010 Jun; 74(3):458-64. PubMed ID: 19398291
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 3. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE, Diaz R, McElmurray J, Csiki I, Duggan D, Lu B, Delbeke D.
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
    Yu HM, Liu YF, Hou M, Liu J, Li XN, Yu JM.
    Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802
    [Abstract] [Full Text] [Related]

  • 5. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
    Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, Ohbayashi C, Sugimura K.
    J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
    [Abstract] [Full Text] [Related]

  • 6. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, Zhou DQ, Dai YM, Lin Y, Lu M, Huang XQ, Xu CX, Chen L.
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [Abstract] [Full Text] [Related]

  • 7. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
    Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W.
    Eur J Radiol; 2010 Feb; 73(2):294-9. PubMed ID: 19181468
    [Abstract] [Full Text] [Related]

  • 8. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
    Zhang HQ, Yu JM, Meng X, Yue JB, Feng R, Ma L.
    Eur J Radiol; 2011 Jan; 77(1):92-6. PubMed ID: 19695804
    [Abstract] [Full Text] [Related]

  • 10. Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in non-small cell lung cancer?
    Wu K, Ung YC, Hwang D, Tsao MS, Darling G, Maziak DE, Tirona R, Mah K, Wong CS.
    J Nucl Med; 2010 Oct; 51(10):1517-23. PubMed ID: 20847172
    [Abstract] [Full Text] [Related]

  • 11. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
    Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC.
    N Engl J Med; 2003 Jun 19; 348(25):2500-7. PubMed ID: 12815135
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
    Jiménez-Bonilla JF, Quirce R, Martínez-Rodríguez I, Banzo I, Rubio-Vassallo AS, Del Castillo-Matos R, Ortega-Nava F, Martínez-Amador N, Ibáñez-Bravo S, Carril JM.
    Lung Cancer; 2013 Jul 19; 81(1):71-6. PubMed ID: 23597930
    [Abstract] [Full Text] [Related]

  • 13. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U, Kremp S, Grosu AL.
    Radiother Oncol; 2006 Nov 19; 81(2):209-25. PubMed ID: 17064802
    [Abstract] [Full Text] [Related]

  • 14. Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
    Kasai T, Motoori K, Horikoshi T, Uchiyama K, Yasufuku K, Takiguchi Y, Takahashi F, Kuniyasu Y, Ito H.
    Eur J Radiol; 2010 Aug 19; 75(2):143-6. PubMed ID: 19446975
    [Abstract] [Full Text] [Related]

  • 15. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.
    Ohno Y, Koyama H, Yoshikawa T, Takenaka D, Seki S, Yui M, Yamagata H, Aoyagi K, Matsumoto S, Sugimura K.
    Radiology; 2015 Jun 19; 275(3):849-61. PubMed ID: 25584709
    [Abstract] [Full Text] [Related]

  • 16. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
    Hahn S, Heusner T, Zhou X, Zhan Y, Peng Z, Hamami M, Forsting M, Bockisch A, Antoch G.
    Rofo; 2010 Mar 19; 182(3):243-7. PubMed ID: 19859858
    [Abstract] [Full Text] [Related]

  • 17. Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients.
    Jeong SY, Lee KS, Han J, Kim BT, Kim TS, Shim YM, Kim J.
    AJR Am J Roentgenol; 2007 Dec 19; 189(6):1407-13. PubMed ID: 18029878
    [Abstract] [Full Text] [Related]

  • 18. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
    Israel O, Kuten A.
    J Nucl Med; 2007 Jan 19; 48 Suppl 1():28S-35S. PubMed ID: 17204718
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M, Okumura T, Kaito K, Kiyoshima M, Asato Y, Uchiumi K, Iijima H, Hashimoto I, Kaburagi T, Amemiya R.
    Ann Nucl Med; 2009 Jan 19; 23(1):49-57. PubMed ID: 19205838
    [Abstract] [Full Text] [Related]

  • 20. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
    Schoellnast H, Larson SM, Nehmeh SA, Carrasquillo JA, Thornton RH, Solomon SB.
    Cardiovasc Intervent Radiol; 2011 Feb 19; 34 Suppl 2():S182-5. PubMed ID: 20508937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.